⌘K

Home/Filings/4/0001209191-20-052405

4//SEC Filing

Combs Andrew 4

Accession 0001209191-20-052405

CIK 0001678660other

View on SEC.gov Company Profile

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 8:11 PM ET

Size

4.8 KB

Accession

0001209191-20-052405

Insider Transaction Report

Form 4

Period: 2020-09-29

Prelude Therapeutics IncPRLD

Chief Chemistry Officer

Transactions

Purchase
Common Stock
2020-09-29$19.00/sh+1,000$19,000→ 260,380 total

Footnotes (1)

[F1]Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1

filerCIK 0001825005

Filing Metadata

Form type: 4
Filed: Sep 28, 8:00 PM ET
Accepted: Sep 29, 8:11 PM ET
Size: 4.8 KB

View on SEC.gov